Reactions Weekly

, Volume 1695, Issue 1, pp 278–278 | Cite as

Natalizumab

Exacerbation of relapsing-remitting multiple sclerosis: case report
Case report
  • 18 Downloads

Reference

  1. Martins J, et al. Clinical worsening after the first infusion of natalizumab in a patient with active relapsing-remitting multiple sclerosis. Sinapse 15: 160-161 abstr. EP1530, No. 1, May 2015 [abstract] - PortugalGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations